Today: 26 March 2026
Subscribe
Browse Category

NASDAQ:TARA 5 December 2025

Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025

Protara Therapeutics (TARA) Stock Plunges After $75 Million Offering: Latest Trial Data, Analyst Targets and Outlook as of December 5, 2025

Protara Therapeutics shares fell about 21% to $5.44 on December 5 after pricing a $75 million public stock offering at $5.75 per share, increasing the share count by roughly 34%. Trading volume surged to 4.8 million shares, well above recent averages. The company’s market cap stood near $260 million, with institutional holders owning nearly 79%. The offering is expected to close on or about December 8.
5 December 2025
·

Stock Market Today

  • EPR Properties Valuation Dips Amid 16% Monthly Share Price Decline
    March 26, 2026, 2:59 AM EDT. EPR Properties (EPR) experienced a 16.1% share price drop over the past month, trading about 19% below average analyst price targets. Its price-to-earnings (P/E) ratio stands at 15.1x, significantly lower than the peer average of 23.8x and the North American specialized REIT sector average of 26.4x, suggesting the stock may be undervalued. The market's caution possibly reflects sector risks related to experiential tenants. Simply Wall St's discounted cash flow (DCF) model values EPR at $123.95 per share, far above the current $49.51, highlighting a notable valuation gap. Investors must balance potential upside against uncertainties in analyst and intrinsic valuations amid the recent pullback.
Go toTop